Functional, metabolic and ultrastructure evidence for improved myocardial protection during severe ischaemic stress with MBS, a new crystalloid cardioplegic solution

Journal of Cardiovascular Surgery

Volumn 37, Issue 3, 1996, Pages 275-284

  Choong, Y S ^a   Gavin, J B ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cardioplegia crystalloid; Hypothermia moderate; Ischemic arrest; Myocardial preservation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASPARTIC ACID; CARDIOPLEGIC AGENT; GLUCOSE; GUANOSINE TRIPHOSPHATE; LACTIC ACID; LACTOBIONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CLAMPING; AORTA PRESSURE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; GLYCOLYSIS; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART OUTPUT; HEART PROTECTION; HEART STROKE VOLUME; MALE; MICROVASCULATURE; NONHUMAN; RAT; REPERFUSION; SINUS RHYTHM; TEMPERATURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASPARTIC ACID; BICARBONATES; CALCIUM CHLORIDE; CARDIOPLEGIC SOLUTIONS; DISACCHARIDES; GLUCOSE; GUANOSINE TRIPHOSPHATE; HEART; HEART ARREST, INDUCED; HEMODYNAMIC PROCESSES; MAGNESIUM; MALE; MICROSCOPY, ELECTRON; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHOCREATINE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; SODIUM CHLORIDE; TIME FACTORS;

EID: 0029972023     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Melrose DG, Dreyer B, Bentall HH, Baker JBE. Elective cardiac arrest. Lancet 1955;2:21-3
2. McFarland JA, Thomas LB, Gilbert JW, Marrow AG. Myocardial necrosis following elective cardiac arrest induced with potassium citrate. J Thorac Cardiovasc Surg 1960;40:200-8.
3. Helmsworth JA, Kaplan S, Clark LC Jr et al Myocardial injury associated with asystole induced with potassium citrate. Ann Surg 1959;149:200-6
4. Bjork VO, Fors B Induced cardiac arrest. J Thorac Cardiovasc Surg 1961;41:387-94
5. Gay WA, Ebert PA. Functional, metabolic and morphologic effect of potassium-induced cardioplegia Surgery 1973;74:284-8.
6. Silverman NA, del Nido P, Krukenkamp I, Levitsky S. Biologic rationale for formulation of antegrade cardioplegic solutions. In: Chitwood WR, editor Cardiac Surgery state of the art review Philadelphia Hanley & Belfus, 1988;2(2):181-96
7. Kinoshita K, Oe M, Tokunaga K. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischaemic myocardium Clinical study m comparison with St Thomas Hospital solution. J Thorac Cardiovasc Surg 1991; 101:695-702.
8. Yau TM, Ikonomidis JS, Weisel RD et al Which techniques of cardioplegia prevent ischaemia? Ann Thorac Surg 1993;56:1020-8.
9. Hearse DJ. Cardioplegia. Postgrad Med 1983;59(Suppl 2):11-24.
10. Hearse DJ, Stewart DA, Braimbridge MV. Hypothermic arrest and potassium arrest. Metabolic and myocardial protection during elective cardiac arrest Circ Res 1975;36:481-9.
11. Coetzee A, Kotze J, Louw J, Lochner A. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart. J Thorac Cardiovasc Surg 1986:91:259-69.
12. Humphrey SM, Choong YS, Buckman JE, Gavin JB. Influence of storage volume on functional recovery and metabolism of explanted hearts following cold cardioplegia, studies in the rat. Cardiovasc Res 1991;25:719-26
13. Choong YS, Cottier DS, Edgar SG. Protective effects of oxygenated St. Thomas' Hospital cardioplegic solution during ischaemic cardiac arrest: improved function, metabolism and ultrastructure. J Cardiovasc Surg 1993;34:423-33.
14. Tabayashi K, McKeown PP, Miyamoto M et al Ischaemic myocardiac protection, comparison of non-oxygenated crystalloid, oxygenated crystalloid and oxygenated flurocarbon cardioplegic solutions J Thorac Cardiovasc Surg 1988;95:239-46
15. Schwalb H, Izhai U, Yaroslavsky E et al. The effect of ammo acids on the ischaemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation J Thorac Cardiovasc Surg 1989;98:551-6
16. Rosenkranz ER, Okamoto F, Buckberg GD et al. Safety of prolonged aortic clamping with blood cardioplegia III Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischaemic and reperfusion injury. J Thorac Cardiovasc Surg 1986;91-428-35.
17. Choong YS, Gavin JB, Cottier D. Functional and metabolic recovery of hearts arrested with L-aspartate and glucose enriched cardioplegic solutions J Mol Cell Cardiol 1992;24(Suppl 1).S158(Abstract).
18. von Oppel UO, du Toit EF, King LM et al. St Thomas' Hospital cardioplegic solutions. Beneficial effect of glucose and multidose reinfusion of cardioplegic solution. J Thorac Cardiovasc Surg 1991;102:405-12.
19. Robinson LA, Braimbridge MV, Hearse DJ. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate. J Thorac Cardiovasc Surg 1987;93 415-27.
20. Sharov VG, Saks VA, Kupriyanov VV et al. Protection of ischaemic myocardium by exogenous phosphocreatine I Morphologic and phosphorus 31-nuclear magnetic resonance studies. J Thorac Cardiovasc Surg 1987;94:749-61.
21. Bolling SF, Bies LE, Bove EL, Gallagher KP. Augmenting intracellular adenosine improves myocardial recovery. J Thorac Cardiovasc Surg 1990;99:470-4.
22. Barne HB, Swartz MT, Devine JE et al Diltiazem as an adjunct to cold blood potassium cardioplegia, a clinical assessment of dose and prospective randomization. Ann Thorac Surg 1987;43:191-7
23. Ledingham SJM, Braimbridge MV, Hearse DJ. The St. Thomas' Hospital cardioplegic solution: a comparison of the efficacy of two formulations. J Thorac Cardiovasc Surg 1987;93:240-6
24. Robinson LA, Braimbridge MV, Hearse DJ. Comparison of the protective properties of four clinical crystalloid cardioplegic soluton in the rat heart Ann Thorac Surg 1984;38:268-74
25. Robinson LA, Harwood DL Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improved protection during hypothermic ischaemia. J Thorac Cardiovasc Surg 1991;101:314-25.
26. Choong YS, Cottier DS, Gavin JB. Myocardial protection during prolonged ischaemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions. J Cardiovasc Surg 1994;35:35-44
27. Holliss DG, Humphrey SM, Morrison MA, Seeelye RM Reverse phase HPLC for rapid comprehensive measurement of nucleotides, nucleosides and bases of the myocardial adenine pool. Anal Lett 1984;17(B18):2047-65.
28. Gutman I, Wahlefeld AW. L(+)-Lactate. Determination with lactate dehydrogenase and NAD In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York: Academic Press, 1974;3:1464-8.
29. Armiger LC, Humphrey SM, West EJN, Knell CM. The effects of raised phosphate level on the energy metabolism, contractile function and fine structure of oxygented and oxygen deficient myocardium Heart Vessels 1986;2:6-14.
30. Choong YS, Gavin JB L-Aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4°C. J Thorac Cardiovasc Surg 1990;99:510-7
31. Swain JL, Sabina RL, McHale PA et al. Prolonged myocardial nucleotide depletion after brief ischaemia in open-chest dog. Am J Physiol 1982;242:H818-826
32. Humphrey SM, Holliss DG, Seelye RM Myocardial adenine pool depletion and recovery of mechanical function following ischaemia. Am J Phyil 1985;248:H644-H51.
33. Torchiana DF, Love TR, Hendren WG et al Calcium-induced ventricular contraction during cardioplegic arrest J Thorac Cardiovasc Surg 1989;94:606-13.
34. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischaemic contracture in globully underperfused rat hearts. Circ Res 1990;66 344-54.